Having confirmed that NRF2-imprinted macrophages potentiate metastasis in a reductionist setting, we next asked whether myeloid NRF2 similarly accelerates tumor progression during spontaneous, therapy-naïve carcinogenesis. This evidence concerns the gene NFE2L2 and neoplasm.